Viewing Study NCT07124559


Ignite Creation Date: 2025-12-24 @ 2:42 PM
Ignite Modification Date: 2026-01-01 @ 7:05 PM
Study NCT ID: NCT07124559
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-15
First Post: 2025-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module